Odonate Therapeutics, Inc. Aktie - Unternehmensdaten & Kurse - US6760792050 | goSPATZ

Odonate Therapeutics, Inc.

Share · US6760792050 (OTC)

No Price

n/a

Company Profile for Odonate Therapeutics, Inc. Share

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

AI Analysis of Odonate Therapeutics, Inc.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Odonate Therapeutics, Inc.

No AI threads available for this company yet.

Company Data

Name Odonate Therapeutics, Inc.

Company Odonate Therapeutics, Inc.

Website https://www.odonate.com

Primary Exchange

UTC

ISIN US6760792050

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kevin C. Tang

Market Capitalization 24 Mrd.

Country United States of America

Currency USD

Employees 0,1 T

Address 3 East 28th Street, 10016 New York City

IPO Date 2017-12-07

Ticker Symbols

Name	Symbol
Over The Counter	ODTC

More Shares

Investors who hold Odonate Therapeutics, Inc. also have the following shares in their portfolio:

Jinan High-tech Development Co., Ltd. Share

NEVADA POWER 2037 R Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026